Clinical benefit of long-term lipoprotein apheresis in patients with severe hypercholesterolemia or Lp(a)-hyperlipoproteinemia with progressive cardiovascular disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1861-0714
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Clinical benefit of long-term lipoprotein apheresis in patients with severe hypercholesterolemia or Lp(a)-hyperlipoproteinemia with progressive cardiovascular disease ; volume:10 ; number:1 ; day:12 ; month:2 ; year:2015 ; pages:8-13 ; date:4.2015
Clinical research in cardiology supplements ; 10, Heft 1 (12.2.2015), 8-13, 4.2015
- Urheber
-
Heigl, Franz
Hettich, Reinhard
Lotz, Norbert
Reeg, Harduin
Pflederer, Tobias
Osterkorn, Dirk
Osterkorn, Klaus
Klingel, Reinhard
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11789-015-0071-3
- URN
-
urn:nbn:de:101:1-2019090502554368595659
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Heigl, Franz
- Hettich, Reinhard
- Lotz, Norbert
- Reeg, Harduin
- Pflederer, Tobias
- Osterkorn, Dirk
- Osterkorn, Klaus
- Klingel, Reinhard
- SpringerLink (Online service)
Ähnliche Objekte (12)
Pregnancy in a Woman with Homozygous Familial Hypercholesterolemia Not on Low-Density Lipoprotein Apheresis
Current Role of Lipoprotein Apheresis
An update on lipid apheresis for familial hypercholesterolemia
Lipoprotein apheresis is an optimal therapeutic option to reduce increased Lp(a) levels
Impact of selective LDL apheresis on serum chemerin levels in patients with hypercholesterolemia
Lipoprotein apheresis affects the concentration of extracellular vesicles in patients with elevated lipoprotein (a)
Lipoprotein glomerulopathy treated with LDL-apheresis (Heparin-induced Extracorporeal Lipoprotein Precipitation system): a case report
Vascular access for lipid apheresis: a challenge in young children with homozygous familial hypercholesterolemia
Low-density lipoprotein cholesterol goal attainment in patients with clinical evidence of familial hypercholesterolemia and elevated Lp(a)
Lipoprotein(a) is associated with DNA damage in patients with heterozygous familial hypercholesterolemia
Lipoprotein(a) apheresis in patients with peripheral arterial disease: rationale and clinical results
Lipoprotein apheresis: an established therapeutic modality for homozygous familial hypercholesterolemia patients refractory to PCSK9 inhibitors: a case report and literature review
Pregnancy in a Woman with Homozygous Familial Hypercholesterolemia Not on Low-Density Lipoprotein Apheresis
Current Role of Lipoprotein Apheresis
An update on lipid apheresis for familial hypercholesterolemia
Lipoprotein apheresis is an optimal therapeutic option to reduce increased Lp(a) levels
Impact of selective LDL apheresis on serum chemerin levels in patients with hypercholesterolemia
Lipoprotein apheresis affects the concentration of extracellular vesicles in patients with elevated lipoprotein (a)
Lipoprotein glomerulopathy treated with LDL-apheresis (Heparin-induced Extracorporeal Lipoprotein Precipitation system): a case report
Vascular access for lipid apheresis: a challenge in young children with homozygous familial hypercholesterolemia
Low-density lipoprotein cholesterol goal attainment in patients with clinical evidence of familial hypercholesterolemia and elevated Lp(a)
Lipoprotein(a) is associated with DNA damage in patients with heterozygous familial hypercholesterolemia
Lipoprotein(a) apheresis in patients with peripheral arterial disease: rationale and clinical results
Lipoprotein apheresis: an established therapeutic modality for homozygous familial hypercholesterolemia patients refractory to PCSK9 inhibitors: a case report and literature review
Pregnancy in a Woman with Homozygous Familial Hypercholesterolemia Not on Low-Density Lipoprotein Apheresis
Current Role of Lipoprotein Apheresis
An update on lipid apheresis for familial hypercholesterolemia
Lipoprotein apheresis is an optimal therapeutic option to reduce increased Lp(a) levels
Impact of selective LDL apheresis on serum chemerin levels in patients with hypercholesterolemia
Lipoprotein apheresis affects the concentration of extracellular vesicles in patients with elevated lipoprotein (a)
Lipoprotein glomerulopathy treated with LDL-apheresis (Heparin-induced Extracorporeal Lipoprotein Precipitation system): a case report
Vascular access for lipid apheresis: a challenge in young children with homozygous familial hypercholesterolemia
Low-density lipoprotein cholesterol goal attainment in patients with clinical evidence of familial hypercholesterolemia and elevated Lp(a)
Lipoprotein(a) is associated with DNA damage in patients with heterozygous familial hypercholesterolemia
Lipoprotein(a) apheresis in patients with peripheral arterial disease: rationale and clinical results